Can next-generation antibodies offset biosimilar competition?

Nat Rev Drug Discov. 2012 Jun 1;11(6):426-8. doi: 10.1038/nrd3749.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Drug Approval
  • Drug Discovery
  • Drug Industry / economics
  • Drug Industry / trends
  • Europe
  • Humans
  • Legislation, Drug
  • Therapeutic Equivalency

Substances

  • Antibodies, Monoclonal